Petros Pharmaceuticals Inc (PTPI) Cotización

 Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. As previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on January 21, 2022, Metuchen Pharmaceuticals LLC (“Metuchen”), a wholly owned subsidiary of Petros Pharmaceuticals, Inc. (the “Company”), entered into that certain (a) Settlement Agreement (the “Settlement Agreement”) and Security Agreement (the “Security Agreement”), each dated January 18, 2022, with Vivus LLC (the “Secured Party”) and (b) Promissory Note dated January 18, 2022, payable to the order of the Secured Party (the “Promissory Note”). As a result of an event of default under the Settlement Agreement and the Security Agreement existing and continuing by virtue of Metuchen’s failure to pay the Installment (as defined in the Promissory Note) that was due October 1, 2024, all the obligations of Metuchen under the Settlement Agreement and the Security Agreement (the “Obligations”) became immediately due and payable on the date of the Foreclosure Notice (as defined below). As of December 10, 2024, the unpaid amount of the Promissory Note was $7,246,634.90 in principal and $237,300.35 in interest. Interest continues to accrue on the foregoing amount at the default rate of 9% per annum. Pursuant to the Security Agreement, the Secured Party holds a security interest against the Collateral (as defined in the Foreclosure Notice). On December 10, 2024, pursuant to a Notice of Proposal to Accept Pledged Collateral in Partial Satisfaction of Indebtedness Pursuant to Uniform Commercial Code Section 9-620 (the “Foreclosure Notice”), the Secured Party proposed to accept all the Collateral (save and except the Specified License Agreement (as defined in the Security Agreement); collectively, the “Foreclosed Collateral”) in partial satisfaction of the Obligations. The Secured Party further proposed in the Foreclosure Notice that its acceptance of the Foreclosed Collateral would only constitute satisfaction of $2,000,000 worth of the Obligations and would not include any other amounts outstanding under the Promissory Note, the Settlement Agreement, or the Security Agreement, including but not limited to (i) all interest accrued or at any time accruing thereon and (ii) all other sums recoverable by the Secured Party from Metuchen by virtue of the Obligations. On December 13, 2024, Metuchen accepted and agreed to the Foreclosure Notice.

Just viagra action .57 + 110% 

Any news?

.54 + 102% 

Where is everyone running nicely .50 
80% 

Read the filings

Did $15M capital raise 10 months ago so cash should be no problem

Shocker...and some claimed nearly 2 years cash in the bank lol. Large debt on the books.

Careful here …
https://stocktwits.com/KeepItRealistic/message/572708730

PTPI new 52 week low

PTPI new 52 lo

We know what isn't up. Nasty

What's up

Exactly

New lows = new low conversion rates

Likely nearing 8 million shares since another installment payment was due this week. Lost nearly 14 million dollars on less than 6 million in sales. Sales last year were lower than 2022. Patent expiring in 12 months. Lot's of other fun nuggets that most won't bother to read.
This one spells out further dilution it would seem:
Going Concern

Petros has experienced net losses and negative cash flows from operations since our inception. As of December 31, 2023, the Company had cash of approximately $13.3 million, positive working capital of $9.6 million, an accumulated deficit of approximately $98.9 million and used cash in operations during the twelve months ended December 31, 2023, of approximately $7.6 million. The Company does not currently have sufficient available liquidity to fund its operations for at least the next 12 months. These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.

GLTA

$PTPI 10k filed

https://www.otcmarkets.com/filing/html?id=17418536&guid=11Q-knncHeK-B3h

“As of March 26, 2024, the registrant had 6,875,814 shares of common stock outstanding.”

PTPI under $2

FDA meeting tomorrow. Definitely swinging some shares for that IMO.

lots of pre market volume, looking good

https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/tm249589d1_8k.htm

I'm in @ 485 shares. Let's go!

https://www.accesswire.com/844279/petros-pharmaceuticals-successfully-launches-ai-tool-in-collaboration-with-multi-billion-dollar-software-provider

there it is :))

Come on ,let's get back in to the1.60s

Well that's alot of premarket volume

Nice comeback

finally been held for so long

Something is up

great ending
at its high :)))

Nice close 1.66

$PTPI - love it

Getting perky

Nice

Well good morning $PTPI

Yup! Moon mentioned it again yesterday

https://twitter.com/keith_rah/status/1765349096192135247?s=19

BTC is at it again this am

Avg volume (3m) is 907,606

So todays volume is inline with the average

Is it just me? Or all liquidity went towards Crypto and Bitcoin

Added down here in the low 1.50s

I'm keep an eye for the news symbol on the app

Volume down today

No worries

Yep
Your calculations were spot on !
Sorry for being in denial lol

Now you see why I was approximating a million shares per month for these past 5 months. 8 more months to go

In Feb 80% of Lowest 3 closing prices, in last 30 days prior to Payment date was .8 x $1.13

$1,154.000 / (.8x$1.13) = 1.287,946

So 1,287,946 shares were added to float for the Feb Payment

Sorry I haven't followed them BK.

Hey runn ,do you have any opinions on Algo*s therape....Just saw they have a catalyst on Thursday

Could be. We just know large dilution and dwindling cash by eoy.